Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
It’s unclear how many Black participants had health insurance or lived in places where needle exchanges are legal.
A new study has found a sharp decline in opioid access among terminal cancer patients in recent years.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
Researchers examined increasing use of PrEP, expanding access to opioid use disorder treatment and improving engagement with HIV care.
The state will provide prisoners medication-assisted treatment to treat opioid use disorder and is creating more syringe services programs.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
The first national study of opioid use disorder recovery found that staying off such drugs often requires great effort and various services.
Health care facilities serving people who use drugs are well-positioned to initiate hepatitis C testing. But ’they don’t.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.